LTTHF yields 1.67% · PFE yields 6.13%● Live data
📍 LTTHF pulled ahead of the other in Year 1
Combined, LTTHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LTTHF + PFE for your $10,000?
Learning Technologies Group plc, together with its subsidiaries, provides a range of talent and learning solutions, content, services, and digital platforms to corporate and government clients. It operates through Software & Platforms Division, Content & Services Division, GP Strategies, and Other segments. The company's software and platforms comprise Gomo, a cloud-based responsive HTML5 e-learning authoring, distribution, and video platform; Rustici Software that allow companies to create, distribute, manage, and play e-learning-compliant content; PeopleFluent, an integrated talent management and learning solution; and Affirmity, which offers analysis, consulting, training, and software to optimize affirmative action and diversity, and inclusion programs. Its software and platforms also include Watershed, a SaaS learning analytics platform; VectorVMS that delivers software and services for businesses to optimize their contingent workforce programmes; Breezy HR, a recruiting platform and applicant tracking system; Instilled, a structured corporate learning experience platform; Open LMS that helps organizations and institutions to deliver learning experiences; and Bridge, a learning and performance platform. In addition, the company engages in the mobile e-learning and e-learning interoperability businesses; operation of employee benefit trust; and provision of video distribution software. The company operates in the United Kingdom, the United States, the Asia Pacific, Mainland Europe, Canada, and internationally. Learning Technologies Group plc was founded in 1986 and is based in London, the United Kingdom.
Full LTTHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.